TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition.
Chiang S et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2022